WallStreetZenWallStreetZen

NASDAQ: BIIB
Biogen Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BIIB past earnings growth

How has BIIB's earnings growth performed historically?
Company
121.04%
Industry
-4.32%
Market
14.4%
BIIB's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BIIB's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BIIB's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BIIB past revenue growth

How has BIIB's revenue growth performed historically?
Company
-6.61%
Industry
0.65%
Market
14.15%
BIIB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BIIB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BIIB's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BIIB earnings and revenue history

Current Revenue
$10.1B
Current Earnings
$3.1B
Current Profit Margin
31%
BIIB's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BIIB Return on Equity

Current Company
24.2%
Current Industry
41.7%
Current Market
30.8%
BIIB's Return on Equity (24.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BIIB announces earnings.

BIIB Return on Assets

Current Company
12.6%
Current Industry
9.3%
BIIB is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BIIB Return on Capital Employed

Current Company
17.09%
Current Industry
14.6%
BIIB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BIIB vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BIIB$10.10B$4.30B$3.13B-4.31%+9.04%
HZNP$3.58B$841.53M$371.91M+27.55%+36.47%
GSK$36.36B$19.35B$18.31B-3.50%+63.92%
GRFS$6.59B$1.31B$226.39M+4.47%-22.28%
OGN$6.15B$1.59B$746.00M-0.91%-36.78%
View Top General Drug Manufacturer Stocks

BIIB earnings dates

Next earnings date
Jul 18, 2023

Biogen Earnings & Revenue FAQ

What were BIIB's earnings last quarter?

On Invalid Date, Biogen (NASDAQ: BIIB) reported Q1 2023 earnings per share (EPS) of $2.69, up 30.58% year over year. Total Biogen earnings for the quarter were $387.90 million. In the same quarter last year, Biogen's earnings per share (EPS) was $2.06.

If you're new to stock investing, here's how to buy Biogen stock.

What was BIIB's earnings growth in the past year?

As of Q2 2023, Biogen's earnings has grown 121.04% year over year. This is 125.36 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of -4.32%. Biogen's earnings in the past year totalled $3.13 billion.

What is BIIB's earnings date?

Biogen's earnings date is Invalid Date. Add BIIB to your watchlist to be reminded of BIIB's next earnings announcement.

What was BIIB's revenue last quarter?

On Invalid Date, Biogen (NASDAQ: BIIB) reported Q1 2023 revenue of $2.46 billion up 2.72% year over year. In the same quarter last year, Biogen's revenue was $2.53 billion.

What was BIIB's revenue growth in the past year?

As of Q2 2023, Biogen's revenue has grown -6.61% year over year. This is 7.25 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 0.65%. Biogen's revenue in the past year totalled $10.10 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.